Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, Kuma K, Amino N
Department of Laboratory Medicine, Osaka University Medical School, Suita, Japan.
Cancer Res. 1999 Sep 15;59(18):4542-5.
The restricted expression of oncofetal fibronectin (onfFN) mRNA in thyroid papillary and anaplastic carcinomas was recently reported. In this study, we measured the copy number of onfFN mRNA in RNAs extracted from fine needle aspiration biopsies by real-time quantitative reverse transcription-PCR using thyroglobulin mRNA as an internal control. By measuring the onfFN:thyroglobulin mRNA ratio, preoperative aspirates from 31 papillary carcinomas and an anaplastic carcinoma can be distinguished from those from 5 adenomatous goiters, 5 follicular adenomas, and 4 follicular carcinomas. Thus, quantification of onfFN by real-time quantitative reverse transcription-PCR may be useful for the preoperative diagnosis of papillary and anaplastic carcinomas.
最近有报道称癌胚纤连蛋白(onfFN)mRNA在甲状腺乳头状癌和未分化癌中呈限制性表达。在本研究中,我们以甲状腺球蛋白mRNA作为内对照,通过实时定量逆转录PCR测定了细针穿刺活检提取的RNA中onfFN mRNA的拷贝数。通过测量onfFN与甲状腺球蛋白mRNA的比值,31例乳头状癌和1例未分化癌的术前穿刺物可与5例腺瘤性甲状腺肿、5例滤泡性腺瘤和4例滤泡状癌的术前穿刺物区分开来。因此,通过实时定量逆转录PCR对onfFN进行定量分析可能有助于乳头状癌和未分化癌的术前诊断。